Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1901.93 Million | USD 4340.04 Million | 8.6% | 2024 |
The global tissue sealants and tissue adhesive market size was worth around USD 1901.93 Million in 2024 and is predicted to grow to around USD 4340.04 Million by 2034 with a compound annual growth rate (CAGR) of roughly 8.6% between 2025 and 2034. The report analyzes the global tissue sealants and tissue adhesive market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the tissue sealants and tissue adhesive industry.
Sealants are materials used by surgeons to heal tissue that has been injured by surgery or injury. Skin, internal organs, and blood vessels are among the tissues that have been damaged. Sealants are used in combination with mechanical procedures like sutures and staples to assist minimize blood loss and avoiding leaks. Tissue adhesives are liquid monomers that, when exposed to a moist surface (skin), begin an exothermic reaction, transforming into a polymer that establishes a strong tissue connection.
Secure skin closure is very basic and essential step in every surgical procedure. If the skin closure devices fail to provide the required strength and support to the skin tissue, there is a possibility that the wound edges can get separated, or it can offer a potential way for bacterial contamination. A promising alternative to the traditional closure techniques is tissue sealants and tissue adhesives. They form physically powerful bond crossways apposed wound boundaries and allow normal healing to occur below. Tissue sealants and adhesives save time in wound repair, provide a flexible water-resistant defensive coating and eradicate the need for suture removal. Some tissue glue examples are Cyanoacrylate, octyl cyanoacrylate (Dermabond), enbucrilate (Histoacryl), and N-butyl cyanoacrylate (Indermil, Liquiband).
Increase in the number of orthopedic and cardiovascular procedures to foster the market
Over the forecast period, rising cardiovascular and orthopedic surgeries are expected to drive revenue growth in the global tissue sealants and tissue adhesive market. The ease of availability of novel tissue adhesives and tissue sealants among end users, combined with rising disposable money, is a major driver in the global increase in such procedures. Adhesives are essential in general surgery. Natural and manufactured polymeric materials can be used to create three-dimensional networks that adhere to target tissues chemically and physically, acting as adhesives, sealants, or hemostats. Because adhesives and sealants are such an important aspect of general surgery, demand for them will rise as the number of procedures performed increases. As a result, market growth is likely to be boosted.
Less market penetration for tissue sealants and adhesives in developing countries to hinder the growth
The market's growth is also likely to be hampered by the dearth of acceptance of tissue glue and bio-adhesive sealants in developing markets. This is due to a lack of knowledge about the advantages, cost-effectiveness, therapeutic application, and reliability of tissue adhesive and tissue sealants against alternative procedures or products, as well as tissue healing therapies.
Technological advancement for product launches to create numerous opportunities for market growth
Companies have been working on the development of novel tissue glue and bio-adhesive sealants to reach a variety of consumers, including toddlers, and young and elderly patients, during the last few years. Tissue sealants are currently used to protect sensitive, fragile, skin from damage, and to prevent cross-contamination & infection transmission. For innovative product launches, major companies are investing heavily in R&D activities. All such factors are likely to generate numerous opportunities for the global tissue sealants and tissue adhesive market growth during the forecast period.
Limitations in the development of tissue adhesive act as a major challenge to market growth.
Despite the fact that many tissue adhesives form strong connections with tissue, they are frequently not designed for specific tissue applications. Tissue adhesives, in particular, do not biodegrade at a rate consistent with tissue repair, cause an unwanted inflammatory response upon adhesion or disintegration, fail to cohere in high-load-bearing applications, or do not match the characteristics of the underlying tissue. In the early stages of development, rigorous differentiation of target applications and a greater in-depth investigation of tissue-surface features and tissue-environmental parameters are necessary.
Despite the fact that the surface of the tissue and the surrounding environment change amongst tissues, the most typical technique is to utilize one type of adhesive for all conceivable tissues. This "one-size-fits-all" approach frequently results in tissue adhesive misuse, leading to inferior performance and dampening enthusiasm for potentially promising new materials. This could also lead to an incorrect cost-effectiveness analysis for specified unmet clinical requirements in the early stages of development, culminating in an exaggeration of cost in later stages of development and obstructing clinical translation. A failure to understand the physiological effects of adhesive materials after implantation is another factor for the research-to-product mismatch. All such limitations may pose challenges to market growth.
The global tissue sealants and tissue adhesive market is categorized based on product, application, end-user, and region.
Based on the product, the market is divided into semi-synthetic & synthetic adhesives and biological or natural sealants.
The application segment consists of neurosurgery, cosmetic surgery, cardiovascular surgery, gynecology surgery, orthopedic surgery, general surgery, and other applications.
The end-user segment is bifurcated into ambulatory surgery centers, specialty clinics, and hospitals.
Report Attributes | Report Details |
---|---|
Report Name | Tissue Sealants and Tissue Adhesive Market |
Market Size in 2024 | USD 1901.93 Million |
Market Forecast in 2034 | USD 4340.04 Million |
Growth Rate | CAGR of 8.6% |
Number of Pages | 166 |
Key Companies Covered | Integra LifeSciences, C.R Bard, Smith & Nephew, Exapharma, Johnson & Johnson, Baxter International Inc, Tissuemed Ltd, Chemence Medical Inc, Cohera Medical Inc, and Luna Innovations Incorporated, and others. |
Segments Covered | By Product, By Application, By End-user, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America to be the leader in the global market
Among the regions, North America is estimated to lead the global tissue sealants and tissue adhesive market during the forecast period. Because of its large population and technical advancements, North America accounted for the largest share of tissue sealants and tissue adhesive. However, the market for tissue sealants and tissue adhesives is expected to expand significantly in Asia Pacific countries. Factors such as state-of-the-art medical research facilities and rising investments in healthcare infrastructure in this region, and also heightened understanding among both physicians & patients relating therapeutic approaches, enhanced life expectancy, and a rising population will push growing demands for tissue sealants and tissue adhesives in the Asia Pacific region.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the tissue sealants and tissue adhesive market on a global and regional basis.
By Product
By Application
By End-user
By Region
FrequentlyAsked Questions
The global tissue sealants and tissue adhesive market is expected to grow due to increasing adoption in surgical procedures, rising demand for wound closure solutions, and technological advancements in bioadhesive materials.
According to a study, the global tissue sealants and tissue adhesive market size was worth around USD 1901.93 Million in 2024 and is expected to reach USD 4340.04 Million by 2034.
The global tissue sealants and tissue adhesive market is expected to grow at a CAGR of 8.6% during the forecast period.
North America is expected to dominate the tissue sealants and tissue adhesive market over the forecast period.
Leading players in the global tissue sealants and tissue adhesive market include Integra LifeSciences, C.R Bard, Smith & Nephew, Exapharma, Johnson & Johnson, Baxter International Inc, Tissuemed Ltd, Chemence Medical Inc, Cohera Medical Inc, and Luna Innovations Incorporated, among others.
The report explores crucial aspects of the tissue sealants and tissue adhesive market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
Increase in the number of orthopedic and cardiovascular procedures to foster the market
Over the forecast period, rising cardiovascular and orthopedic surgeries are expected to drive revenue growth in the global tissue sealants and tissue adhesive market. The ease of availability of novel tissue adhesives and tissue sealants among end users, combined with rising disposable money, is a major driver in the global increase in such procedures. Adhesives are essential in general surgery. Natural and manufactured polymeric materials can be used to create three-dimensional networks that adhere to target tissues chemically and physically, acting as adhesives, sealants, or hemostats. Because adhesives and sealants are such an important aspect of general surgery, demand for them will rise as the number of procedures performed increases. As a result, market growth is likely to be boosted.
Less market penetration for tissue sealants and adhesives in developing countries to hinder the growth
The market's growth is also likely to be hampered by the dearth of acceptance of tissue glue and bio-adhesive sealants in developing markets. This is due to a lack of knowledge about the advantages, cost-effectiveness, therapeutic application, and reliability of tissue adhesive and tissue sealants against alternative procedures or products, as well as tissue healing therapies.
Yes, Technological advancement for product launches to create numerous opportunities for market growth
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed